Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients

Episode 11: Recent Progress in the Treatment ...

Up next

Episode 34: The Rationale for Complement Inhibition in the Management of IgA Nephropathy

In Episode 34, the first in a three-part Conversations in Nephrology series on IgA nephropathy (IgAN), host Brad Rovin, MD (The Ohio State University), KDIGO IgAN/IgAV Guideline Co-Chair, is joined by Dana Rizk, MD (University of Alabama at Birmingham), to explore the rationale f ...  Show more

Episode 33: Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next

In the third episode of the KDIGO Conversations in Nephrology FSGS series, host Dr. Kirk Campbell (University of Pennsylvania) sits down with world-renowned glomerular disease expert Dr. Jai Radhakrishnan (Columbia University) to navigate the shifting landscape of Focal Segmental ...  Show more

Recommended Episodes

ImmunoTea Episode 1 - IL-17 and Neurological Autoimmunity
ImmunoTea: Your Immunology Podcast

On this episode Lara and Vyanka talk to Prof Kingston Mills and Dr Anastasia Zekeridou all about IL-17 and and neurological autoimmunity. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about ...  Show more

OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
The OTA Podcast

Join host Dr. Paul Whiting as he interviews paper authors Drs. Hassan Mir and Mitchell John as they discuss the Notable Paper on treatment of venous thromboembolism. This paper was presented at the OTA 2021 Annual Meeting. For additional educational resources visit https://ota.or ...  Show more

184. Backed Up - An Approach to SVC Syndrome
The Intern At Work: Internal Medicine

Send us Fan MailIn this episode, we discuss the approach to a patient with SVC syndrome. This includes considering both malignant and non-malignant causes. Treatment focuses on relief of the obstruction and investigation and management of malignant causes. Our medicine minute dis ...  Show more